1. Home
  2. CYCU vs GDTC Comparison

CYCU vs GDTC Comparison

Compare CYCU & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

BUY

Current Price

$3.81

Market Cap

9.5M

Sector

N/A

ML Signal

BUY

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.98

Market Cap

10.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCU
GDTC
Founded
2017
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5M
10.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CYCU
GDTC
Price
$3.81
$0.98
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
7.5M
24.1K
Earning Date
06-05-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$17,771,485.00
N/A
Revenue This Year
$8.92
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.68
52 Week High
$7.13
$3.68

Technical Indicators

Market Signals
Indicator
CYCU
GDTC
Relative Strength Index (RSI) 86.39 51.28
Support Level $0.69 $0.93
Resistance Level $4.46 $1.09
Average True Range (ATR) 0.12 0.09
MACD 0.19 0.02
Stochastic Oscillator 91.05 63.33

Price Performance

Historical Comparison
CYCU
GDTC

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: